We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Implantable Micropacemaker Treats Fetal Heart Block

By HospiMedica International staff writers
Posted on 22 Apr 2015
Print article
Image: Comparative sizes of fetal and adult pacemakers (Photo courtesy of Children’s Hospital Los Angeles).
Image: Comparative sizes of fetal and adult pacemakers (Photo courtesy of Children’s Hospital Los Angeles).
A new study describes the first fully implantable micropacemaker designed for dealing with potentially fatal fetal heart block.

Developed by researchers at Children’s Hospital Los Angeles (CHLA; CA, USA) and the University of Southern California (USC; Los Angeles, USA), the miniature pacemaker creates the potential to prevent miscarriages and premature births for those afflicted with fetal heart block, potentially without causing harm to the fetus or to the mother. The micropacemaker, which has already undergone pre-clinical testing, has been designated a humanitarian use device exemption by the US Food and Drug Administration (FDA). The investigators anticipate first human use of the device in the near future.

Although congenital heart block can be diagnosed in utero, all attempts to treat the condition with a standard pacemaker have so far failed, since the size of an adult pacemaker requires that only a small portion be implanted in the fetus, while the electronics remain externalized. This design has uniformly failed, likely due to fetal movement causing the electrodes to become dislodged from the heart. The study describing the fetal micropacemaker was published in the March 2015 issue of Heart Rhythm.

“Up until now, the pacemaker devices that have been used in an attempt to treat this condition in a fetus were designed for adults,” said lead author pediatric cardiologist Yaniv Bar-Cohen, MD, of CHLA. “We have lacked an effective treatment option for fetuses.”

“Building on our experience of using microfabrication techniques to create biomedical devices, we have developed a micropacemaker small enough to reside entirely within the fetus,” said study coauthor Gerald Loeb, MD, a professor of biomedical engineering at the Viterbi School of Engineering at USC. “This will allow the fetus to move freely without risk of dislodging the electrodes.”

Congenital heart block is a defect of the heart’s electrical system that originates in the developing fetus. Within the right atrium of a normal heart is a natural pacemaker that sends an electrical stimulus travels from the pacemaker (SA node) to the ventricles (AV node). If the transmission of the signal is impeded (heart block or an AV block), the transfer of the electrical nerve conduction that regulates the normal, rhythmic, pumping action of the heart muscle is interrupted or slowed. If the heart block occurs in the fetus or newborn, the condition is known as congenital heart block.

Related Links:

Children’s Hospital Los Angeles
University of Southern California


Gold Member
12-Channel ECG
CM1200B
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Surgial Headlight
MedLED Chrome

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.